ursolic acid has been researched along with rosiglitazone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, DW; Lim, SI; Nguyen, PH; Oh, WK; Park, SL; Uddin, MN; Williams, DR; Yang, JL | 1 |
| Li, D; Liu, JH; Wang, GL; Wang, L; Wu, LN; Zhu, DZ | 1 |
| Harini, R; Pugalendi, KV; Sundaresan, A | 1 |
| Pugalendi, KV; Radhiga, T; Sundaresan, A | 2 |
5 other study(ies) available for ursolic acid and rosiglitazone
| Article | Year |
|---|---|
Protein tyrosine phosphatase 1B (PTP1B) inhibitors from Morinda citrifolia (Noni) and their insulin mimetic activity.
Topics: 3T3-L1 Cells; 4-Chloro-7-nitrobenzofurazan; Adipocytes; Animals; Deoxyglucose; Hypoglycemic Agents; Inhibitory Concentration 50; Insulin; Lignans; Mice; Molecular Structure; Morinda; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Republic of Korea | 2013 |
[Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ].
Topics: Adiponectin; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypoglycemic Agents; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones; Triterpenes; Tumor Necrosis Factor-alpha; Ursolic Acid | 2012 |
Ursolic acid and rosiglitazone combination alleviates metabolic syndrome in high fat diet fed C57BL/6J mice.
Topics: Animals; Body Weight; Cyclooxygenase Inhibitors; Dietary Fats; Drug Therapy, Combination; Hypoglycemic Agents; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Triterpenes; Ursolic Acid | 2012 |
Effect of ursolic acid and Rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice.
Topics: Animals; Diet, High-Fat; Drug Therapy, Combination; Fatty Acids; Fatty Liver; Male; Mice; Mice, Inbred C57BL; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Triterpenes; Ursolic Acid | 2014 |
Ursolic acid and rosiglitazone combination improves insulin sensitivity by increasing the skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat diet-fed C57BL/6J mice.
Topics: Animals; Anti-Obesity Agents; Antioxidants; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Therapy, Combination; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; Phosphatidylinositol 3-Kinase; Phosphorylation; Protein Processing, Post-Translational; Protein Transport; Rosiglitazone; Second Messenger Systems; Thiazolidinediones; Triterpenes; Ursolic Acid; Weight Gain | 2016 |